<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>In a cross-sectional study, we assessed beta-cell function and insulin sensitivity index (ISI) with hyperglycemic clamps (10 mmol/l) in 24 subjects with impaired fasting glycemia (IFG, fasting plasma <z:chebi fb="105" ids="17234">glucose</z:chebi> [FPG] between 6.1 and 7.0 mmol/l), 15 type 2 diabetic subjects (FPG &gt;7.0 mmol/l), and 280 subjects with <z:mpath ids='MPATH_458'>normal</z:mpath> fasting glycemia (NFG, FPG &lt;6.1 mmol/l) </plain></SENT>
<SENT sid="1" pm="."><plain>First-phase insulin release (0-10 min) was lower in IFG (geometric mean 541 pmol/l.10 min; 95% confidence interval [CI] 416-702 pmol/l.10 min) and in type 2 <z:mp ids='MP_0002055'>diabetes</z:mp> (geometric mean 376 pmol/l.10 min; 95% CI 247-572 pmol/l.10 min) than NFG (geometric mean 814 pmol/l.10 min; 95% CI 759-873 pmol/l.10 min) (P &lt; 0.001) </plain></SENT>
<SENT sid="2" pm="."><plain>Second-phase insulin secretion (140-180 min) was also lower in IFG (geometric mean 251 pmol/l; 95% CI 198-318 pmol/l; P = 0.026) and type 2 <z:mp ids='MP_0002055'>diabetes</z:mp> (geometric mean 157 pmol/l; 95% CI 105-235 pmol/l; P &lt; 0.001) than NFG (geometric mean 295 pmol/l; 95% CI 276-315 pmol/l) </plain></SENT>
<SENT sid="3" pm="."><plain>IFG and type 2 diabetic subjects had a lower ISI (0.15 plus minus 0.02 and 0.16 plus minus 0.02 micromol/kg fat-free mass [FFM]/min/pmol/l, respectively) than NFG (0.24 plus minus 0.01 micromol/kg FFM/min/pmol/l, P &lt; 0.05) </plain></SENT>
<SENT sid="4" pm="."><plain>We found a stepwise decline in first-phase (and second-phase) secretion in NFG subjects with progressive decline in oral <z:chebi fb="105" ids="17234">glucose</z:chebi> tolerance (P &lt; 0.05) </plain></SENT>
<SENT sid="5" pm="."><plain>IFG subjects with <z:hpo ids='HP_0000833'>impaired glucose tolerance</z:hpo> (IGT) had lower first-phase secretion than NFG subjects with IGT (P &lt; 0.02), with comparable second-phase secretion and ISI </plain></SENT>
<SENT sid="6" pm="."><plain>NFG and IFG subjects with a diabetic <z:chebi fb="105" ids="17234">glucose</z:chebi> tolerance (2-h <z:chebi fb="105" ids="17234">glucose</z:chebi> &gt;11.1 mmol/l) had a lower ISI than their respective IGT counterparts (P &lt; 0.05) </plain></SENT>
<SENT sid="7" pm="."><plain>We conclude that the early stages of <z:hpo ids='HP_0000833'>glucose intolerance</z:hpo> are associated with disturbances in beta-cell function, while <z:hpo ids='HP_0000855'>insulin resistance</z:hpo> is seen more markedly in later stages </plain></SENT>
</text></document>